登录 | 注册    关注公众号  
微信公众号
搜索
 > 【VEGF-C】

VEGF-C信息

英文名称:Vascular endothelial growth factor C
中文名称:血管内皮生长因子C
靶点别称:LMPHM4,Vascular Endothelial Growth Factor-Related Protein,Flt4-L,VRP,FLT4 Ligand DHM,LMPH1D,VEGF-C,Vascular Endothelial Growth Factor C,Flt4 ligand,VEGFC
上市药物数量:0
临床药物数量:3
最高研发阶段:临床三期

VEGF-C产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
VEC-H4225
Human
Human VEGF-C / Flt4-L Protein, His Tag (MALS verified)
ACRO质量管理体系
 
评论(3)
VEC-H4225|Human VEGF-C / Flt4-L Protein, His Tag (MALS verified)
  1. 137XXXXXXX8
  2. 1人赞
  3. 使用该蛋白用于做抗体药物binding评价,实验数据稳定,加快了筛选速度,期待有其他种属(猴,大鼠,兔)产品的出现。
  4. 2022-01-18
VEC-H4225|Human VEGF-C / Flt4-L Protein, His Tag (MALS verified)
  1. 181XXXXXXX6
  2. 0人赞
  3. 我们购买这款蛋白用于筛选抗体,主要用在ELISA实验,这款蛋白灵敏度高,蛋白活性很好,实验取得了很好的数据,一直在Acro购买蛋白,Acro值得信赖。
  4. 2023-09-25
VEC-H4225|Human VEGF-C / Flt4-L Protein, His Tag (MALS verified)
  1. 151XXXXXXX5
  2. 0人赞
  3. acro蛋白一直很好,具有较好的活性,产品包装包括产品使用说明都很方便实验人员,是我们实验室的优选品牌,还会回购
  4. 2022-12-09
 

VEGF-C分子别名

VEGFC,Flt4-L,VRP

VEGF-C分子背景

Vascular endothelial growth factor C is also known as VEGFC, Flt4-L and VRP, it contains the C-terminal propeptide which has an unusual structure with tandemly repeated cysteine-rich motifs. Upon biosynthesis, VEGFC is secreted as a non-covalent momodimer in an anti-parellel fashion. VEGFC is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis, lymphangiogenesis and endothelial cell growth and survival, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. The structure and function of this protein is similar to those of vascular endothelial growth factor D (VEGF-D). VEGFC may function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Overexpression of VEGF-C causes lymphatics to enlarge possibly facilitates metastasis.

VEGF-C临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Sozinibercept OPT-302; VGX-300 临床三期 Orphan Europe Sarl 病理性新生血管, 视网膜病变, 糖尿病黄斑水肿, 视网膜变性, 眼部疾病, 年龄相关性黄斑变性 详情
VEGF-C gene therapy (Herantis Pharma) LX-1101; Ad-VEGF-C 临床二期 Herantis Pharma 淋巴水肿 详情
IBI-333 IBI-333 临床一期 Innovent Biologics (Usa), Inc 湿性黄斑变性, 年龄相关性黄斑变性 详情

消息提示

请输入您的联系方式,再点击提交!

确定